Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity.

Tissue antigens - 1 Dec 2003

Berretta F, Butler R H, Diaz G, Sanarico N, Arroyo J, Fraziano M, Aichinger G, Wucherpfennig K W, Colizzi V, Saltini C, Amicosante M

Abstract excerpt

The polymorphism at position beta69 of the human leukocyte antigen (HLA)-DP molecule has been associated with susceptibility to several immune disorders and alloreactivity. Using molecular modeling, we have predicted a detailed structure of the HLA-DP2 molecule (carrying Glubeta69) complexed with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Substitution
Share to Cell Line, Tumor
Share to Glutamic Acid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA-DP Antigens

Share to Hydrogen-Ion Concentration

Share to Lysine

Share to Peptides

Share to Recombinant Proteins

Source

Identifiers

PMID: 14617029
DOI: 10.1046/j.1399-0039.2003.00131.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-14617029-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity.PMID 14617029Read ↗

Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach.Semantic proximity Read ↗

HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity.Semantic proximity Read ↗

Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705.Semantic proximity Read ↗

Pocketcheck: updating the HLA class I peptide specificity roadmap.Semantic proximity Read ↗

Crystal structure of HLA-DP2 and implications for chronic beryllium disease.Semantic proximity Read ↗

The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.Semantic proximity Read ↗

Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule.Semantic proximity Read ↗

Unraveling the structural basis for the unusually rich association of human leukocyte antigen DQ2.5 with class-II-associated invariant chain peptidesSemantic proximity Read ↗

Modulation of peptide binding by HLA-B27 polymorphism in pockets A and B, and peptide specificity of B*2703.Semantic proximity Read ↗

A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins.Semantic proximity Read ↗

Human T cells recognize HLA-DP–bound peptides in two orientationsSemantic proximity Read ↗

The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.